In conclusion, we showed non-mitogenic FGF2 maintains the ability for acute cardioprotection from Dox cardiomyocyte toxicity while lacking characteristics that are undesirable in a cancer environment, such as the potential for CK2 activation and upregulation of HO-1. Here, HMOX1 is linked to cancer.